Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Clinical evolution

Fate seeks partners to be iPS Catalyst

26-May-2009 -  There has been “tremendous interest” in Fate Therapeutics’ Catalyst programme, which gives access to induced iPS cell technology as part of collaborative relationship between numerous companies.

Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit

20-May-2009 - UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its...

BerGenBio RNAi services attract biotechs

20-May-2009 - BerGenBio is at BIO 2009 presenting its CellSelectRNAi technology and other services, which in the four months the company has been operational have landed it a multi-million dollar deal with...

Patheon aims to be "provider of choice" for cell assays

20-May-2009 - Canadian contract services group Patheon will roll out a cell based assay offering that it says will help the biopharmaceutical sector advance the development of the next generation of biologic...

Global trials call for global ethics, says NEJM study

14-May-2009 -  The increasingly global clinical trial sector demands more effective ethical and regulatory scrutiny according to a study published in the latest edition of the New England Journal of Medicine (NEJM)....

Encorium to sell US and Finnish units

13-May-2009 -  CRO Encorium has unveiled plans to sell both its US business and its Finnish subsidiary Encorium Oy just weeks after posting a gloomy set of Q1 financials dominated by a...

News in brief

ERT relocates to accommodate growth

13-May-2009 -  eClinical service provider ERT has relocated to a facility in Philadelphia, US that is double the size of the previous site. 

Cisiv launches Baseline Plus for "real world" trials

07-May-2009 - UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials.

FDA rules on adaptive trials would help sector, says PI

07-May-2009 -  Definitive FDA guidance on adaptive trials cannot come soon enough for the pharmaceutical and biotech sectors, according to Perceptive Informatics (PI). 

News in brief

CMED and Tessella team up on trials

07-May-2009 -  CRO CMED and IT group Tessella are teaming up to offer adaptive trial data management and acquisition services to the drug industry.

Charles River maintains 2009 guidance; preclinical orders “stabilise”

06-May-2009 -  Charles River Laboratories (CRL) has bucked the CRO sector trend and reaffirmed its forecasts for 2009, citing an improved order book and better pricing as the reasons for its relative...

Perceptive’s Alzheimer’s imaging aims to cut costs

05-May-2009 -  Perceptive Informatics has expanded its offering for trials involving Alzheimer's disease with a new medical imaging method, which it claims produces higher quality, reproducible and regulatory compliant assessments.

Encorium Group signs $2m in new contracts, results indicate tough market

30-Apr-2009 -  US contract research organisation (CRO) Encorium has reported $2m in new and repeat business deals on the same day it posted gloomy Q4 figures and cited the "drop in demand"...

Covance is latest CRO to cut 2009 forecast on lower Q1 demand

30-Apr-2009 -  New Jersey, US based Covance is the latest CRO to cut earnings projections and blame falling pharmaceutical industry demand for its woes.

Microsoft launches Amalga for R&D and trial data management

29-Apr-2009 -  US software giant Microsoft has unveiled its new Amalga Life Sciences data aggregation and modelling platform in a bid to capitalise on the demand for IT infrastructure solutions currently sweeping...

News in brief

DCS and NextDocs team up on compliance doc management

29-Apr-2009 -  DCS Hosted Solutions and NextDocs are teaming up to provide pharma and biotech firms with a compliance document management system that cuts the time taken to commercilize drugs. 

News in brief

Mene accredited under new Turkish trial regs

28-Apr-2009 -  Turkish CRO Mene Research has become the first trials group to be accredited by the country’s Ministry of Health under new trial laws introduced in January. 

CPI adds TrialMaster EDC tech to offering

27-Apr-2009 - German CRO Clinicalprojects International (CPI) will begin providing its customers with the TrialMaster EDC solution though a deal with developer OmniComm. 

Project cancellations dominate Kendle’s gloomy Q1 forecast

22-Apr-2009 - US firm Kendle is the latest CRO to revise its forecast and blame “unprecedented biopharmaceutical industry conditions,” which are fast becoming an industry catchphrase, for its Q1 woes.

Bio-Path calls in Acorn to help with siRNA drug trial

22-Apr-2009 -  Bio-Path Holdings has called in US CRO Acorn to provide a contract medical officer for a study of its candidate antisense cancer drug liposomal Grb-2. 

PhRMA revises principles to increase transparency

21-Apr-2009 -  Following calls for increased transparency PhRMA has published its new clinical trial principles, which contain revisions relating to registration, authors and sponsor disclosure.

ChemDiv buys Russia’s Prudentas

20-Apr-2009 -  US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching...

Siro ClinPharm and ACT team up on oncology

20-Apr-2009 -  Indian CRO Siro ClinPharm is teaming up with New Jersey based pharma services firm Advanced Clinical Trial Solutions (ACT) to strengthen its position in the US cancer trial sector.

Mandatory registration for Indian clinical trials

17-Apr-2009 -  From June onwards drug firms and CROs conducting trials in India are required to record full details of the research, including the funding source, on the ICMR’s Clinical Trials Registry...

Recruitment a growing problem for trials, says CEI

17-Apr-2009 - Finding appropriate subjects in the booming trials market is a major stumbling block for drug firms and CROs, according to a new study by US market analysts Cutting Edge Information

Key Industry Events


Access all events listing

Our events, Shows & Conferences...